Diagnosis of ADEM
ADEM is diagnosed through a combination of acute encephalopathy (altered mental status or behavioral changes not explained by fever) plus MRI evidence of multifocal demyelinating lesions during the first 3 months of symptom onset, with no subsequent new MRI findings—this remains a clinical diagnosis of exclusion requiring careful elimination of mimics. 1
Core Diagnostic Criteria
The diagnosis requires two essential components working together:
Clinical Features
- Encephalopathy is mandatory - look for altered consciousness, behavioral changes, or confusion that cannot be attributed to fever alone 1
- Polyfocal neurologic deficits - multiple areas of CNS involvement presenting acutely or subacutely 2
- Common presentations include:
MRI Findings (Brain and Spine)
- Ill-defined, reversible white matter lesions - typically large, poorly demarcated, and bilateral 2
- Frequent involvement of deep gray matter - thalami and basal ganglia are characteristically affected 2
- Tumefactive appearance during acute phase with gadolinium enhancement 3
- Spinal cord involvement is common, often showing longitudinally extensive lesions
- Key distinguishing feature: No new lesions on follow-up MRI after initial 3-month period 1
CSF Analysis
While not diagnostic, lumbar puncture typically shows 2:
- Mild pleocytosis (elevated white blood cells)
- Elevated protein
- Critically: Generally negative for oligoclonal bands (helps distinguish from MS)
Diagnostic Algorithm
Suspect ADEM when: Child or young adult presents with acute encephalopathy plus multifocal neurologic symptoms, often 1-2 weeks after viral illness or vaccination 2, 4
Obtain brain and spine MRI with and without gadolinium - look for the characteristic pattern described above 3
Perform lumbar puncture - to exclude infectious causes and assess for oligoclonal bands 2
Rule out ADEM mimics (this is critical as ADEM is a diagnosis of exclusion):
- Multiple sclerosis (look for oligoclonal bands, absence of encephalopathy, new lesions over time)
- NMOSD (test for aquaporin-4 antibodies)
- MOGAD (test for MOG antibodies - though MOG-positive cases may represent a distinct entity) 2
- Infectious encephalitis
- Metabolic disorders
- Neoplastic processes
Follow-up MRI at 3-6 months - to confirm monophasic nature (no new lesions) 1
Important Caveats
The absence of a specific biomarker makes this challenging - there is no single test that confirms ADEM 5. The diagnosis relies heavily on pattern recognition and temporal evolution.
MOG antibodies are controversial - while some ADEM patients test positive for anti-MOG antibodies, the significance remains debated, and these may represent a separate disease entity 2.
Age matters - ADEM predominantly affects children under 10 years, with peak incidence in early childhood 5, 1. Adult presentations should prompt more aggressive exclusion of MS and other conditions.
Timing is critical - the monophasic nature means symptoms develop acutely (days to weeks), plateau, then improve. Any recurrence beyond 3 months or new MRI lesions should prompt reconsideration of the diagnosis 2.
Don't wait for complete workup to treat - if clinical suspicion is high based on encephalopathy plus MRI findings, initiate immunotherapy promptly while completing diagnostic evaluation, as early treatment improves outcomes 6.